| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/25/1995 | US5410068 Succinimidyl trityl compounds and a process for preparing same |
| 04/25/1995 | US5410018 Bombesin-related peptides |
| 04/25/1995 | US5409810 Nucelic acid derivatives |
| 04/25/1995 | CA1335356C Therapeutic uses of 2',5'-oligoadenylates |
| 04/21/1995 | CA2118153A1 Use of nucleosides and nucleoside derivatives provided with enzymatically cleavable protecting groups in the synthesis of oligonucleotides |
| 04/20/1995 | WO1995010777A1 Detection and treatment of breast and gynecological cancer |
| 04/20/1995 | WO1995010776A1 Hybridoma and anti-kc-4 humanized monoclonal antibody, dna and rna encoding it, kit, diagnostic and therapeutic methods |
| 04/20/1995 | WO1995010630A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | WO1995010625A1 Dna encoding 1,3-beta-d glucan synthase subunits |
| 04/20/1995 | WO1995010606A1 Deoxyribonucleic acids containing inactivated hormone responsive elements |
| 04/20/1995 | WO1995010539A1 Growth differentiation factor-10 |
| 04/20/1995 | WO1995010307A1 Radiation sensitization using texaphyrins |
| 04/20/1995 | WO1995010305A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
| 04/20/1995 | CA2178341A1 Detection and treatment of breast and gynecological cancer |
| 04/20/1995 | CA2174136A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | CA2172271A1 Deoxyribonucleic acids containing inactivated hormone responsive elements |
| 04/20/1995 | CA2171546A1 Growth differentiation factor-10 |
| 04/19/1995 | EP0648842A2 Truncated human cholesterol 7alpha-hydroxylase, method of production and use thereof |
| 04/19/1995 | EP0648841A2 Genomic DNA of human Cholesterol 7alpha-hydroxylase and methods for using it |
| 04/19/1995 | EP0648493A1 A method to reverse the phenotype of transformed cells by the transcription factor IRF-1 |
| 04/19/1995 | EP0648280A1 Method and reagent for determining specific nucleotide variations |
| 04/19/1995 | EP0648269A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications |
| 04/19/1995 | EP0648266A1 Elicitor of the hypersensitive response in plants |
| 04/19/1995 | EP0648261A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
| 04/19/1995 | EP0648222A1 Methods of single nucleotide primer extension to detect specific alleles and kits therefor |
| 04/19/1995 | EP0648221A1 Trityl monitor for automated polynucleotide synthesis |
| 04/19/1995 | EP0648220A1 Deuterated nucleosides |
| 04/19/1995 | EP0648128A1 DNA ENCODING PRECURSOR INTERLEUKIN 1$g(b) CONVERTING ENZYME |
| 04/19/1995 | EP0517796B1 Oligonucleotide analogs |
| 04/19/1995 | EP0436016B1 Chimeric anti-cea antibody |
| 04/18/1995 | US5407801 Forming linker arm by bisulfite-catalyzed transamination at specific deoxycytidine site; hybridizing duplex to triplex |
| 04/18/1995 | US5407798 Amplification of midivariant DNA templates |
| 04/18/1995 | US5407797 Oligonucleotide probes and methods for detecting by hybridization the nucleic acids of bacteria and other living organisms |
| 04/18/1995 | US5407795 CMV probes for use in solution phase sandwich |
| 04/13/1995 | WO1995009924A1 Tia-1 binding proteins and isolated complementary dna encoding the same |
| 04/13/1995 | WO1995009921A1 Platelet-activating factor acetylhydrolase |
| 04/13/1995 | WO1995009912A1 Stem cell proliferation factor |
| 04/13/1995 | WO1995009656A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | WO1995009655A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 04/13/1995 | WO1995007718A3 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 04/13/1995 | WO1995006727A3 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
| 04/13/1995 | CA2173495A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 04/13/1995 | CA2173217A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | CA2151261A1 Tia-1 binding proteins and isolated complementary dna encoding the same |
| 04/13/1995 | CA2133872A1 Molecules influencing the shedding of the tnf receptor, their preparation and their use |
| 04/12/1995 | EP0647849A2 Detecting the presence of analytes in a sample |
| 04/12/1995 | EP0647280A1 Over expression of single-stranded molecules |
| 04/12/1995 | EP0647275A1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 04/12/1995 | EP0647270A1 Novel malignant cell type markers of the interior nuclear matrix |
| 04/12/1995 | EP0647139A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
| 04/12/1995 | EP0214971B1 Yeast strains producing cellulolytic enzymes and methods and means for constructing them |
| 04/11/1995 | US5405950 N4 -substituted cytidines and process for incorporation into an oligonucleotides |
| 04/11/1995 | US5405942 Prepro insulin-like growth factors I and II |
| 04/11/1995 | US5405939 2',5'-phosphorothioate oligoadenylates and their covalent conjugates with polylysine |
| 04/11/1995 | US5405938 Sequence-specific binding polymers for duplex nucleic acids |
| 04/11/1995 | US5405783 Removing photoremovable protective group from region of substrate, contacting with protected amino acid, repeating to form peptide |
| 04/11/1995 | US5405776 Genetic engineering |
| 04/11/1995 | US5405771 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 04/11/1995 | US5405585 Designed for handling different type of fluids in flow system and reduces chemical reagent cross contamination; used for nuclic acid and other biosynthesis; automatic |
| 04/06/1995 | WO1995009236A1 USING ANTISENSE OLIGONUCLEOTIDES TO MODULATE NERVE GROWTH AND TO REVERSE β/A4 AMYLOID-INDUCED MORPHOLOGY |
| 04/06/1995 | WO1995009180A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | WO1995009176A1 Biopolymer synthesis utilizing surface activated, organic polymers |
| 04/06/1995 | WO1995009025A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS) |
| 04/06/1995 | WO1995009011A1 Methods of stimulating phagocytosis |
| 04/06/1995 | WO1995009010A1 Arteriosclerosis remedy |
| 04/06/1995 | WO1995009004A1 Compositions containing growth factors and antiplastic agents |
| 04/06/1995 | WO1995006718A3 Methods of suppressing autoimmune response |
| 04/06/1995 | CA2172978A1 Arteriosclerosis remedy |
| 04/06/1995 | CA2172729A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | CA2172728A1 Vaccine for branhamella catarrhalis |
| 04/06/1995 | CA2172393A1 Methods of stimulating phagocytosis |
| 04/06/1995 | CA2171553A1 Using antisense oligonucleotides to modulate nerve growth and to reverse .beta./a4 amyloid-induced morphology |
| 04/06/1995 | CA2167589A1 Biopolymer synthesis utilizing surface activated, organic polymers |
| 04/06/1995 | CA2149657A1 Compositions containing growth factors and antiplastic agents |
| 04/05/1995 | EP0646181A1 Use of nucleic acid analogues in the inhibition of nucleic acid amplification. |
| 04/05/1995 | EP0646178A1 expression cassette with regularoty regions functional in the mammmlian host |
| 04/05/1995 | EP0646172A1 Recombinant entomopoxvirus |
| 04/05/1995 | EP0646170A1 DIABETOGENE $i(rad): A TYPE II DIABETES SPECIFIC GENE |
| 04/05/1995 | EP0646129A1 Receptor-type tyrosine kinase-like molecules |
| 04/05/1995 | EP0646124A1 A genetically engineered cell line for detecting infectious herpes simplex virus and method therefor |
| 04/05/1995 | EP0646013A1 Platelet derived growth factor antagonists |
| 04/05/1995 | EP0277212B1 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor |
| 04/05/1995 | EP0180615B1 Novel atrial natriuretic/vasodilator polypeptides |
| 04/04/1995 | US5403924 Taga gene and methods for detecting predisposition to peptic ulceration |
| 04/04/1995 | US5403711 Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled nucleic acid probe is cleaved |
| 04/04/1995 | US5403710 Nucleic acid probes and methods for detecting pathogenic candida yeasts |
| 04/04/1995 | US5403708 Ligands hybridized to nucleic acid template |
| 03/30/1995 | WO1995008644A1 Self-sustained sequence replication electrochemiluminescent nucleic acid assay |
| 03/30/1995 | WO1995008642A1 Nucleic acid detection with energy transfer |
| 03/30/1995 | WO1995008635A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof |
| 03/30/1995 | WO1995008631A2 Target antigens of transmission blocking antibodies for malaria parasites |
| 03/30/1995 | WO1995008629A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 03/30/1995 | WO1995008622A1 Recombinant infectious laryngotracheitis virus and uses thereof |
| 03/30/1995 | WO1995008556A1 Reagents comprising chimeric molecules of nucleic acids and nucleic acid analogs |
| 03/30/1995 | WO1995008555A1 2',5'-oligoadenylate-2',3'-cyclophosphates |
| 03/30/1995 | WO1995008554A1 Nf-at polypeptides and polynucleotides |
| 03/30/1995 | WO1995008541A1 Conformationally locked nucleoside analogues |
| 03/30/1995 | WO1995008333A1 Use of 2',5'-oligoadenylates for treatment of papillomatoses |
| 03/30/1995 | WO1995005452A3 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 03/30/1995 | WO1994028153A3 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |